167
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer

, , &
Pages 4937-4948 | Published online: 13 May 2022

References

  • Buskwofie A, David-West G. Clare CA: a review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–232. doi:10.1016/j.jnma.2020.03.002
  • Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71(4):313–320. doi:10.23736/S0026-4784.19.04397-1
  • Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–465. doi:10.1016/j.currproblcancer.2018.06.003
  • Gong Y, Fan Z, Luo G, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100. doi:10.1186/s12943-019-1029-8
  • Zhe-Wei S, Li-Sha G, Yue-Chun L. The role of necroptosis in cardiovascular disease. Front Pharmacol. 2018;9:721. doi:10.3389/fphar.2018.00721
  • Choi ME, Price DR, Ryter SW, Choi AMK. Necroptosis: a crucial pathogenic mediator of human disease. JCI Insight. 2019;4(15). doi:10.1172/jci.insight.128834
  • Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14:48. doi:10.1186/s12943-015-0321-5
  • Wang N, Liu D. Identification and validation a necroptosis‑related prognostic signature and associated regulatory axis in stomach adenocarcinoma. Onco Targets Ther. 2021;14:5373–5383. doi:10.2147/OTT.S342613
  • Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19(1a):A68–77. doi:10.5114/wo.2014.47136
  • Liu L, Bai X, Wang J, et al. Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer. Clin Cancer Res. 2019;25(24):7413–7423. doi:10.1158/1078-0432.CCR-19-0558
  • Samstein RM, Lee CH, Shoushtari AN, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019;51(2):202–206. doi:10.1038/s41588-018-0312-8
  • Mehrotra R, Yadav K. Cervical Cancer: formulation and Implementation of Govt of India guidelines for screening and management. Indian J Gynecol Oncol. 2022;20(1):4. doi:10.1007/s40944-021-00602-z
  • Feng Y, Wang Y, Xie Y, Wu S, Li Y, Li M. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer. BMC Cancer. 2021;21(1):450. doi:10.1186/s12885-021-08209-5
  • Li M, Ren CX, Zhang JM, et al. The effects of miR-195-5p/MMP14 on proliferation and invasion of cervical carcinoma cells through TNF signaling pathway based on bioinformatics analysis of microarray profiling. Cell Physiol Biochem. 2018;50(4):1398–1413. doi:10.1159/000494602
  • Bai Y, Li H, Lv R. Interleukin-17 activates JAK2/STAT3, PI3K/Akt and nuclear factor-κB signaling pathway to promote the tumorigenesis of cervical cancer. Exp Ther Med. 2021;22(5):1291. doi:10.3892/etm.2021.10726
  • Mei J, Xing Y, Lv J, et al. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer. Int Immunopharmacol. 2020;88:106882. doi:10.1016/j.intimp.2020.106882
  • Chen Q, Hu L, Huang D, Chen K, Qiu X, Qiu B. Six-lncRNA immune prognostic signature for cervical cancer. Front Genet. 2020;11:533628.
  • Zhao Z, Liu H, Zhou X, et al. Necroptosis-related lncRNAs: predicting prognosis and the distinction between the cold and hot tumors in gastric cancer. J Oncol. 2021;2021:6718443. doi:10.1155/2021/6718443
  • Wu X, Xi X, Yan Q, et al. MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Med Oncol. 2013;30(4):751. doi:10.1007/s12032-013-0751-0
  • Liu S, Song L, Yao H, et al. Preserved miR-361-3p expression is an independent prognostic indicator of favorable survival in cervical cancer. Dis Markers. 2018;2018:8949606. doi:10.1155/2018/8949606
  • Xu L, Xu Q, Li X, Zhang X. MicroRNA-21 regulates the proliferation and apoptosis of cervical cancer cells via tumor necrosis factor-α. Mol Med Rep. 2017;16(4):4659–4663. doi:10.3892/mmr.2017.7143
  • Li J, Xie L, Xie Y, Wang F. Bregmannian consensus clustering for cancer subtypes analysis. Comput Methods Programs Biomed. 2020;189:105337. doi:10.1016/j.cmpb.2020.105337
  • Sadanandam A, Lyssiotis CA, Homicsko K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013;19(5):619–625. doi:10.1038/nm.3175
  • Diao P, Jiang Y, Li Y, et al. Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response. J Immunother Cancer. 2021;9(6):e002434. doi:10.1136/jitc-2021-002434